Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters (Q24244042)

8

0 references

Francesca Sperati

6

0 references

Elie A Akl

1

0 references

Deborah J. Cook

7

object named as

Deborah Cook

0 references

Victor E D Yosuico

3

object named as

Victor E D Yosuico

0 references

author name string

Ganesh Kamath

2

0 references

Seo Young Kim

Cochrane Database of Systematic Reviews

4

0 references

publication date

18 July 2007

0 references

published in

0 references

cites work

Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies--a randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Prophylactic urokinase in the management of long-term venous access devices in children: a Children's Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Thromboembolic complications related to indwelling central venous catheters in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Catheter-associated thrombosis: thromboprophylaxis or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Thrombotic complications of central venous catheters in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

The thrombophilic state induced by therapeutic agents in the cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Randomized trials stopped early for benefit: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Prognosis of Cancers Associated with Venous Thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter-related infections in patients with haemato-oncological diseases: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

7 January 2021

Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler‐ultrasound

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

7 January 2021

Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

7 January 2021

Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Yes for special patient groups

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

7 January 2021

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

7 January 2021

Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

7 January 2021

Thrombosis: the major Hickman catheter complication in patients with solid tumor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

7 January 2021

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006468.PUB2

7 January 2021